Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist.
作者信息
Tunney Michael M, Wark Peter
机构信息
Halo Research Group, School of Pharmacy, Queen's University Belfast, Belfast, UK
College of Health Medicine and Wellbeing, University of Newcastle, New Lambton, Australia.
出版信息
Eur Respir J. 2023 Aug 3;62(2). doi: 10.1183/13993003.01008-2023. Print 2023 Aug.
PMID:37536727
Abstract
摘要
Zotero 插件